chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Lower back pain; Urinary tract infection; Irregular period; This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3182) via an unspecified route of administration on 03Sep2021 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was reported as not applicable. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. Concomitant medications included norethisterone acetate, ethinylestradiol, ferrous fumarate (TAYTULLA), acetylcysteine (NAC), and levomefolic acid (L-METHYLFOLATE); all taken for unspecified indications from unknown dates and unknown if ongoing. On 05Sep2021, the patient experienced lower back pain, urinary tract infection, irregular period. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included an unspecified treatment. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events lower back pain, urinary tract infection, irregular period were unknown at the time of the report.  No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a registered nurse concerning a patient of unknown age and gender. No concurrent conditions or medical history were reported. On 03-JAN-2016, it was reported that the patient received an improperly stored dose of MMR II (lot # L023385, exp date on 25-JUN-2017). No adverse effects were reported. No Product Quality Complaint (PQC) was involved. Only 3 doses of MMR II were administered. The registered nurse also reported temperature excursion. High temperature excursion: Temperature: 14C Time frame: 11 hours. Low temperature excursions: Temperature IC Time frame: 11 hours. This is one of several reports received from the same source. Additional information has been requested.
Pt recv vax on 3/8/99; on 3/10/99 pt exp swelling of proximal/ mid joints in hands, painful &red feet; 3/11/99 pt exp rash on hands, trunk, legs &feet tx=Benadryl & Ibuprofen
rash on chest that moved to non vaccine arm and then back to vaccine arm over the course of a few days
Narrative: COVID infection following COVID vaccine series 04/11 Janssen, dose #1 (hospital) 12/06 Pfizer, dose #2 1/5 COVID swab, result: detected 12/28 pt cc: malaise, wheezing, headache, sinus congestion exposure; unknown 12/30 pt admit ED cc: malaise, wheezing, headache, sinus congestion dx: COVID LOS: 1 DAY 12/30 CXR impression: 1. No pneumonia. 2. Possible right pulmonary nodule. Recommend PA and lateral chest radiograph in the nonacute setting.
Swelling of lymph nodes left armpit (injection arm)  I had not experienced that in previous first and second shot
Dizziness, Headache, Myalgia, Arthralgia, Fever, CoughWheeze, Chills, shortness of breath, cough, chest tightness Narrative: respiratory and flu like symptoms which began approximately 5 hours after vaccine administration. Required her to miss 1 day from work
Rapid Breathing-respirations 50-60 min.  Fever: 102-103 F; Tachycarida-115-120/min (symptoms resolved with in 24 hours after onset); Lethargy/weakness.
Called back to get his shot and there were 2 patient. Patient came back with his mom. I gave Moderna and then as I was explaining when to come back for Moderna mom realized he was under 18 and it was the wrong patient
This spontaneous case reported by a consumer, describes the occurrence of headache, pyrexia (fever) and myalgia (muscle pain) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 081B21A) for COVID-19 immunization. No medical history reported. On Mar 12, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 12, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 12, 2021, patient experienced headache, pyrexia (fever) and myalgia (muscle pain). The patient treated with Tylenol (paracetamol), at an unspecified dose and frequency; and ibuprofen, at an unspecified dose and frequency. At the time of the report, headache, pyrexia (fever) and myalgia (muscle pain) outcome: unknown. No relevant concomitant medications reported.
I noticed about 3-4 hours after the injection that my right upper arm was swelling. My entire upper arm became red, hot to the touch, extremely swollen, and painful. This lasted for about 36 hours after onset, the pain being so severe that I considered seeking emergency care. It has been 72 hours since the vaccination, and the swelling and pain have largely passed, but my arm is still red and tender. The redness, swelling, and pain did not center on the injection site, but rather formed below the area where the shot was administered.
He ran a slight fever of 101 later that evening when the TYLENOL wore off. The next day at daycare, he ran a high fever of 102.3. He showed no other signs of illness other than the high fever. I gave him Ibuprofen and alternated with TYLENOL for about 12 hours to keep his fever down since he's had a febrile seizure before.
Wrong formulation influenza vaccine given to child FLUZONE and should have been FLUZONE QUAD. Dose given 0.5 ml - should have been 0.25 ml.
Starting from 10:30pm the same day of my booster Pfizer appt, I started feeling very tired then my whole body started to ache really bad. My hands and feet were really cold and I felt like I was freezing. I put on more clothes and went under my comforter and was still freezing cold. No fever but my whole body's muscles ached really bad and I felt like my left arm was going to fall off. The muscles on the left side of my neck started to become stiff and my heart started beating extremely fast. I took a Tylenol and some of the symptoms went away but today (12/28) I still feel like I am sick maybe with a terrible cold and my whole body aches.
No adverse events; Administered one month after Prevnar 13; This spontaneous report was received from a registered nurse referring to a patient of an unknown age and gender. Information on the patient's pertinent medical history, concurrent conditions and concomitant medications were not reported. Historical drugs included PREVNAR 13 on 21-NOV-2018. On 21-DEC-2018 (reported as one month after receiving PREVNAR 13), the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) lot # R011632, Expiry date: 02-FEB-2020 (dose, route and anatomical location were not reported) for prophylaxis (Inappropriate schedule of product administration). No adverse events reported.
1/15/2021. Right before bed I felt the need to scratch my left deltoid, and it felt like it had a little burning sensation to it.  Today 1/16/2021. The left deltoid area in which I received my shot is reddened. 9 days after the actual vaccination.  It?s very mild, but I thought it was worth reporting.
Dizziness, Myalgia, Fever & HYPOtension Narrative:
Huge swelling around my eyes and redness and tenderness; My left eye was swollen shut; Huge swelling around my eyes and redness and tenderness; My left eye was swollen shut; Huge swelling around my eyes and redness and tenderness; My left eye was swollen shut; This is a spontaneous report from a contactable consumer (patient).  A 64-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number EL0140) via an unspecified route of administration on left arm on an unspecified date at a single dose for covid-19 immunization. The patient had a heart condition and a stroke. The patient concomitant medications were not reported. The patient stated that she had a when I had the shot on the 13th (not clarified) and end up going to urgent care on Friday. She had a huge swelling around her eyes and redness and tenderness and her left eye was swollen shut. She went to urgent care and got some antibiotics and some cream to put on it. The patient had not any lab test. However, she did have microblading done to her eyebrows, three days before she had the shot. The patient wanted to know if it was because she had the microblading done and then she got the shot.  The outcome of the events was unknown.
Fluid Filled lesions back, face, Trunk 10/28/2005, not Dr confirmed, mother called the nurse helpline of school 10/31, 11/01 and 11/02 2005.
Urticaria; Pruritus. Methylprednisolone 125 mg once, diphenhydramine, prednisone.
Painful dark pink swelling 25 cent-size rxn to shot on thigh (where VARIVAX given the day before - (phone call 24 hours after shot).  Repeat phone call next day - large 1 1/2 in diameter with lighter ring outer -> seen in after clinic - C.O.M. - 3cm red firm mild tender area with 1 cm pink circumference.
Normal labor and delivery on 12/7/2021. Hospital admission within 6 weeks of receiving the COVID vaccine.
Of concern is great difficulty hearing and significant balance problems.  Fever has subsided.  Fatigue and aches are diminishing.
Patient stated she had upper lip welts and facial tingling Patient provided water and symptoms diminished Patient refused medical transport and signed form
After getting flu shot, the next morning site was very red, swollen and frim, tender to touch, tender to move left arm.  This resolved 4 days after injection. Pt reports Pins-and -needles sensation in left hand and forearm on the ulnar side.  Reports continues numbness and paresthesia of LUE for 2 weeks.  Reports random sensations "pulsing and lightning bolts".
pt recvd vax & w/in 20seconds post vax pt exp a blackout which was of short duration w/full recovery;this had occurred @ end of a busy day;dental procedure in the morning, PE, tuberculosis test, & tetanus vax;also exp runny nose & diarrhea;
Extreme pain on right side under the lower ribs necessitating a visit to Primary Care Physician. Felt like my organs were too big for my torso. Pain began Saturday or Sunday (I don't remember which) after vaccination Friday afternoon. Saw PCP on Monday.
28 hrs after vaccine, woke up with tinnitus R ear, partial hearing loss R ear - went to Urgent care - Dr diagnosed with right sensorineural hearing loss with left side unrestricted hearing - prescribed prednisone 60mg a day x10days.  Audiology test to be scheduled next week.
Information has been received from a physician concerning a 23 year old female with allergies to erythromycin who was vaccinated with first, second, and third dose of GARDASIL on 29-APR-2008. 30-JUN-2008  and 29-OCT-2008 respectively. The third dose of GARDASIL (lot # was 661530/0575X) was IM, 0.5 ml. There was no concomitant medication. On 30-OCT-2008, the patient experienced an injection site reaction after her third dose of GARDASIL. The symptoms included 11 by 7 cm induration with pain and inability to lift her arm. The site was warm to the touch. She also reported stiffness in her fingers. At the time of the report, the patient was recovering. The physician saw the patient. Additional information has been requested. This is in follow-up to report(s) previously submitted on 11/14/2008. Follow-up information has been received from a physician concerning a 23 year old female who was vaccinated with the third dose of GARDASIL in left upper arm. Concomitant medication included albuterol HFA inhaler. On 31-OCT-2008 (previously reported as 30-OCT-2008) the patient experienced adverse event after her third dose of GARDASIL. At the time of the report, the patient was recovered. The patient did not seek medical attention (previously reported the physician saw the patient). No further information is available.
ADULT OBSTRUCTIVE SLEEP APNEA, SEVERE 11/18/2022 LEFT ANKLE FX INIT  ADULT OBSTRUCTIVE SLEEP APNEA, SEVERE 11/18/2022 ADULT OBSTRUCTIVE SLEEP APNEA, SEVERE  ADULT OBSTRUCTIVE SLEEP APNEA, SEVERE 11/18/2022 CKD STAGE 3A (GFR 45-59)
Information has been received from a physician concerning a 5 month old male who in November 2007 and January 2008, was vaccinated with his first and second dose of Rotateq. In 2008 the patient experienced three stools lacking in color, slightly elevated liver function tests and gall stones. The patient sought unspecified medical attention. The outcome was unknown. There was no product quality complaint. Additional information has been requested.
After the vaccine, I started feeling a cold coming on Wednesday morning, tired, headache. I didn't think anything of it. I kept getting worse over the weekend after Thanksgiving. My granddaughter came home from day care on Monday and was exposed to COVID at daycare. I took all the grandchildren and herself to the ER and tested positive. I did a test at home and, I was positive. I went to a testing site and was positive as well. Health department called me and made sure I talked to my doctor. I had a phone appointment with my doctor, and it had been a week since I was sick and still didn't feel well. She told me to take ibuprofen as needed and to keep taking in fluids. Cold symptoms, chills, coughing, fever, diarrhea. Started feeling better Wednesday 12/8 of this week. Health department had cleared me after 12/5. Doctor suggested for me to stay home until today 12/10. Doctor said it could have been a coincidence with vaccine and exposure - doesn't feel like it was because of the vaccination.
severe muscular tightness upper arms/neck, back, chest;called MD;sx lessened by end of wk x/for chest;still aches & have SOB;chest tightness;
I had fever on Saturday as I did with first dose; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fever. On an unknown date, the outcome of the fever was unknown.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccinaation was not reported. The age group of the patient was not reported but selected as an adult as per vaccine indication. The reporter stated that, had fever after 1st dose of Shingrix. For the tolerence of 2nd dose refer case US2020AMR230269.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR230269:Same reporter
This non-valid spontaneous report was received from a nurse practitioner, concerning an unspecified number of patients of unknown ages and genders. The patients' medical history, concurrent conditions, drug reactions, allergies and concomitant medications were not reported. The nurse informed that on unspecified dates, the patients were vaccinated with improperly stored GARDASIL 9 for prophylaxis, lot #N001533 and expiration date 16-OCT-2019; lot #N004798 and expiration date 31-OCT-2019; lot #N009801 and expiration date 20-NOV-2019; lot #N010497 and expiration date 15-JAN-2020; lot #N004799; lot #N20352 and expiration date 10-APR-2020; lot #N007931 and expiration date 07-NOV-2019; and lot #N0013276 and expiration date 21-JAN-2020 (strength, dose, frequency and route of administration were not reported); with improperly stored M-M-R II one single injection, for prophylaxis, lot #N001007 and expiration date 13-JAN-2019; lot #N009171 and expiration date 20-MAR-2019; lot #N001532 and expiration date 13-JAN-2019; lot #N020352 and expiration date 04-MAY-2019; lot #M045395 and expiration date 04-NOV-2018; lot #N001531 and expiration date 13-JAN-2019 and a non-valid lot #M045396 and expiration date 14-NOV-2018 (strength, dose and route of administration were not reported); with improperly stored VAQTA for prophylaxis, lot #N005605 and expiration date 13-JAN-2018 and lot #N012324 and expiration date 05-APR-2018 (strength, dose, frequency and route of administration were not reported); with improperly stored PNEUMOVAX 23 for prophylaxis, lot #N001007 and expiration date 09-SEP-2018; lot #N014946 and expiration date 01-FEB-2019; lot #N011867 and expiration date 08-NOV-2018; lot #N011491 and expiration date 04-NOV-2018; and lot #M047519 and expiration date 04-AUG-2018 (strength, dose, frequency and route of administration were not reported) and with improperly stored RECOMBIVAX HB for prophylaxis, lot #M046373 and expiration date 04-NOV-2018; non-valid lot #N000321 and expiration date 08-NOV-2019 and lot #N006321 and expiration date 08-NOV-2018 (strength, dose, frequency and route of administration were not reported). The vaccines were reconstitued with an improperly stored sterile diluent (MERCK STERILE DILUENT) for prophylaxis (strenght, dose, lot number and expiration date were not reported). The reporter denied any adverse effect reported by the patients. The nurse reported that the time frames and temperatures of excursions were as follows: 47°F to 77°F (48.5°F) during a time frame of 3 hours and 30 minutes; below 32°F / 0°C (31.8°F) during a time frame of 126 hours; bellow 32°F / 0°C (17.3°F) during a time frame of 6 hours and 30 minutes; 47 °F to 77°F (49.8°F) during a time frame of 66 hours and 30 minutes; 47°F to 77°F (52.7°F) during a time frame of 3 hours and 30 minutes: 47 °F to 77 °F (52.3°F) duing a time frame of 160 hours and below 32°F / 0°C (31.5°F) during a time frame of 16 hours. There was no previous temperature of excursion reported. There was a digital data logger involved. As of 19-FEB-2018, all telephone attempts to obtain follow-up information were unsuccessful.
fever--highest recorded at 101.3, shivers,body aches, nausea and vomiting, extreme fatigue, spent most of the following day sleeping,lack of appetite, symptoms felt like i had covid virus again, tylenol for fever, by evening on 3/21 temperature had gone down and was feeling quite a bit better, no temperature on 3/22--still some body aches and light headed
Patient denied having received flu vaccine for the 2021 flu season. Believed 10-05-21 Flu shot at PHC was an error on CAIR2 Immunization History Report. After receiving High-Dose Flu shot at Covid Clinic this day. The patient reported that he had received a flu shot at PHC Clinic on 10-05-21 as recorded.
patient is 15 months old and received 2 dose series of flu second year in a row.  no adverse effects noted, patient was notified immediately by provider and advised to follow up if any adverse effects.
Developed weakness, vomiting, body aches 4/21/06. Seen 4/24/06 and admitted to Hospital with weakness, severe malagias,headache, photophobis,hypertension, and anorexia. 4/26/06 transferred to PICU at Medical Center. Developed progressive weakness. Lumbar puncture 5/3/06 showed protein of 176 c/w Guillain-Barre syndrome. Intubated 5/3/06. Received IV-IG for 2 courses. Discharged home on 6/5/05 from PICU with residual lower extremity weakness. Discharge summary states pain, irritability, incontinent, tachypneq, sinisitis, respiratory arrest. msv. 60 day Follow-up Information 22-AUG-2006: Still with mild residual leg weakness, intermittent "shooting" pains down legs.
injection site became welt up and it was a little larger than a half dollar and probably the size of a plum; low grade temperature; injection site hard lump; injection site felt bruised inside; injection site became red, tender to touch and painful; injection site was tender to touch and painful; injection site became red; Initial information received on 18-Aug-2020 regarding an unsolicited valid non-serious case from a consumer or non-health care professional (patient).  This case is linked to cases 2020SA229160, 2020SA219448 and 2020SA218631 (same reporter).  This case involves a 40-years-old female patient who experienced injection site felt bruised inside (vaccination site bruising), injection the site became red, tender to touch and painful (vaccination site inflammation, vaccination site erythema, vaccination site pain), injection site became welt up and it was a little larger than a half dollar and probably the size of a plum(vaccination site urticaria), injection site hard lump (vaccination site mass) and low grade temperature (pyrexia), while she received DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL].  The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.   On 22-Jul-2020, the patient received a dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (lot number: U6638AA, expiry date: 04-Dec-2022) via an unknown route in the left deltoid for prophylactic vaccination.  On an unknown date, the patient developed a non-serious  injection site felt bruised inside (vaccination site bruising), injection the site became red, tender to touch and painful (vaccination site inflammation, vaccination site erythema, vaccination site pain), injection site became welt up and it was a little larger than a half dollar and probably the size of a plum(vaccination site urticaria), injection site hard lump (vaccination site mass) and low grade temperature (pyrexia), within a two week period following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE..  Laboratory details included body temperature results not reported.   An unknown corrective treatment was received.  The outcome of events was unknown.
Pt had mild fever and injection side pain the next day after the vaccine (5/28/2022). she was taking ibuprofen. She felt better later in the afternoon
Redness, soreness at injection site.  Fever of 101.1. Chills, aches, facial redness/flushing. Same reaction with dose 1 in the series in Oct of 2018.  Last 2-3 days,with arm soreness lasting 4 days
muscle weakness to that left arm; itched really badly; It was red; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (muscle weakness to that left arm), INJECTION SITE PRURITUS (itched really badly) and INJECTION SITE ERYTHEMA (It was red) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced MUSCULAR WEAKNESS (muscle weakness to that left arm), INJECTION SITE PRURITUS (itched really badly) and INJECTION SITE ERYTHEMA (It was red). The patient was treated with HYDROCORTISONE (CORTISONE [HYDROCORTISONE]) for Itching and Swelling, at an unspecified dose and frequency. At the time of the report, MUSCULAR WEAKNESS (muscle weakness to that left arm), INJECTION SITE PRURITUS (itched really badly) and INJECTION SITE ERYTHEMA (It was red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported No treatment information were provided   This case was linked to MOD-2021-255382 (Patient Link).